Detection of analytes using fluorescent energy transfer

• US 5,439,797 A
• Filed: 08/30/1993
• Issued: 08/08/1995
• Est. Priority Date: 07/02/1990
• Status: Expired due to Fees

• Current Assignee: Regents of the University of California (University of California)
• Original Assignee: Regents of the University of California (University of California)
• Inventors: Taylor, Susan S., Ji, Ying, Tsien, Roger Y., Adams, Stephen R.
• Primary Examiner(s): SAUNDERS, DAVID A
• Application Number:
  US08/114,103
• Time in Patent Office: 708 Days
• Field of Search: 435/7.1, 435/7.21, 435/15, 436/501, 436/800
• US Class Current: 435/7.21
• CPC Class Codes: G01N 33/542 with steric inhibition or signal modification, e.g. fluorescent quenching
• CPC Class Codes: G01N 33/582 with fluorescent label
• CPC Class Codes: Y10S 436/80 Fluorescent dyes, e.g. rhodamine

Abstract

The invention provides labeled proteins suitable for determining the presence of cAMP, other second messengers and organic molecules. The proteins are separately labeled with fluorochromes which, when in close spatial proximity, preferably, less than about 6 nm, interact through the transfer of energy from one fluorochrome to the other.

A composition of matter, (S₁.A)_n1 (S₂.D)_n2 is provided wherein S₁ and S₂ are two proteins which are associated in one state and substantially disassociated in another, the equilibrium between which is controlled by the free concentration of an analyte, and A and D are fluorochromes, the emission wavelength of fluorochrome D overlapping the excitation wavelength of fluorochrome A and the distance between A and D being in sufficiently close proximity to allow the radiationless transfer of energy between the fluorochromes. A and D can be selected from a variety of acceptor, donor pairs such as fluorescein and tetramethylrhodamine and derivatives thereof. The concentration of analytes such as cAMP in a sample can be determined by contacting the sample with (S₁.A)_n1 (S₂.D)_n2 providing energy near the excitation wavelength of D and measuring the fluorescence of A or D, the concentration of cAMP and other said analytes being determined by the ratio of emission of D to the emission of A, previously calibrated with reference solutions of known analyte concentration.

Claims

1. A composition of matter, comprising (S₁.A)_n1 and (S₂.D)_n2, wherein S₁ is the regulatory subunit of adenosine 3'"'"', 5'"'"'-cyclic monophosphate dependent protein kinase and S₂ is the catalytic subunit of adenosine 3'"'"', 5'"'"'-cyclic monophosphate dependent protein kinase, and wherein D and A are different fluorochromes the emission wavelength of D overlapping the excitation wavelength of A, and D and A are in sufficiently close proximity to allow radiationless transfer of energy between the fluorochromes, and wherein n1 and n2 represent the stoichiometry of said subunits in said composition.

2. The composition of matter of claim 1, wherein D and A are selected from the group consisting of:

fluorescein and tetramethylrhodamine,

a 7-aminocoumarin and dipyrromethene-borate,

an indocarbocyanine and rhodamine X, and

a phycoerythrin and allophycocyanin,

or derivatives thereof,

provided that the selected pair exhibit fluorescence energy transfer.

3. The composition of matter of claim 1, wherein the emission wavelength of D and the excitation wavelength of A are about 510 to 550 nm.

4. The composition of matter of claim 3, wherein the fluorochromes are fluorescein and tetramethylrhodamine or derivatives thereof.

5. The composition of matter of claim 1, wherein n1 is 2 and n2 is 2.

6. The composition of matter of claim 1, wherein S₁ and S₂ are recombinant proteins.

7. The composition of matter of claim 1, wherein one protein is a recombinant protein and one protein is derived from mammalian sources.

8. The composition of matter of claim 1, wherein S₁ and S₂ are derived from mammalian sources.

9. A composition of matter, comprising (S₁.A)_n1 and (S₂.D)_n2, wherein S₁ is the catalytic subunit of adenosine 3'"'"', 5'"'"'-cyclic monophosphate dependent protein kinase, and S₂ is the regulatory subunit of adenosine 3'"'"', 5'"'"'-cyclic monophosphate dependent protein kinase, and wherein D and A are different fluorochromes the emission wavelength of D overlapping the excitation wavelength of A and D and A are in sufficiently close proximity to allow radiationless transfer of energy between the fluorochromes, and wherein n1 and n2 represent the stoichiometry of said subunits in said composition.

10. The composition of claim 9, wherein D and A are selected from the group consisting of:

fluorescein and tetramethylrhodamine;

a 7-aminocoumarin and dipyrromethene-borate;

an indocarbocyanine and rhodamine X; and

a phycoerythrin and allophycocyanin, or

derivatives thereof,

provided that the selected pair exhibit fluorescence energy transfer.

11. The composition of matter of claim 9, wherein the emission wavelength of D and the excitation wavelength of A are about 510 to 550 nm.

12. The composition of matter of claim 9, wherein S₁ and S₂ are recombinant proteins.

13. The composition of matter of claim 9, wherein one protein is a recombinant protein and one protein is derived from mammalian sources.

14. The composition of matter of claim 9, wherein S₁ and S₂ are derived from mammalian sources.

15. A method of determining the concentration of adenosine 3'"'"', 5'"'"'-cyclic monophosphate in a sample comprising:

(a) forming the complex represented by the formula (S₁.A)_n1 and (S₂.D)_n2, wherein S₁ is the regulatory subunit of adenosine 3'"'"', 5'"'"'-cyclic monophosphate dependent protein kinase and S₂ is the catalytic subunit of adenosine 3'"'"', 5'"'"'-cyclic monophosphate dependent protein kinase, and wherein D and A are different fluorochromes the emission wavelength of D overlapping the excitation wavelength of A, and D and A in said complex are in sufficiently close proximity to allow radiationless transfer of energy between the fluorochromes, and wherein n1 and n2 represent the stoichiometry of said subunits in said complex;

(b) contacting the complex with the sample;

(c) exposing said sample to radiative energy near the excitation wavelength of D; and

(d) measuring the fluorescence emitted at the emission wavelength of at least one of D and A is.

16. The method of claim 15, wherein the measuring step comprises measuring the fluorescence emitted at the emission wavelength of both A and D, wherein the extent of energy transfer from D to A is determined by the ratio of the emission amplitude of A to the emission amplitude of D.

17. The method of claim 15, wherein the measuring step comprises measuring the fluorescence emitted at the emission wavelength of D and determining the extent of the energy transfer from D to A by the fluorescence lifetime of D or the rate of photobleaching of D.

18. The method of claim 15, wherein the sample comprises an intact cell and the contacting step comprises incorporating the complex into the cell.

19. The method of claim 18, wherein the contacting step is selected from the group consisting of microinjection, electroporation, lipofection, bead loading and scrape loading.

20. The method of claim 15, wherein D and A are selected from the group consisting of:

fluorescein and tetramethylrhodamine;

a 7-aminocoumarin and dipyrromethene-borate;

an indocarbocyanine and rhodamine X; and

a phycoerythrin and allophycocyanin,

or derivatives thereof,

provided that the selected pair exhibit fluorescence energy transfer.

21. The method of claim 15, wherein the emission wavelength of D and the excitation wavelength of A are about 510 to 550 nm.

22. The method of claim 20 or 21, wherein the fluorochromes are fluorescein and tetramethylrhodamine or derivatives thereof.

23. The method of claim 15, wherein n1 is 2 and n2 is 2.

24. The method of claim 15, wherein S₁ and S₂ are recombinant proteins.

25. The method of claim 15, wherein one protein is a recombinant protein and one protein is derived from mammalian sources.

26. The method of claim 15, wherein S₁ and S ₂ are derived from mammalian sources.

27. A method according to claim 15, wherein the measuring step comprises measuring the fluorescence emitted at the emission wavelength of A, wherein the extent of energy transfer from D to A is determined by the amplitude of said emission.

28. A method of determining the concentration of adenosine 3'"'"', 5'"'"'-cyclic monophosphate in a sample comprising:

(a) forming a complex represented by the formula (S₁.A)_n1 and (S₂.D)_n2, wherein S₁ is the catalytic subunit of adenosine 3'"'"', 5'"'"'-cyclic monophosphate dependent protein kinase and S₂ is the regulatory subunit of adenosine 3'"'"', 5'"'"'-cyclic monophosphate dependent protein kinase, and wherein D and A are different fluorochromes the emission wavelength of D overlapping the excitation wavelength of A, and D and A in said complex are in sufficiently close proximity to allow radiationless transfer of energy between the fluorochromes, and wherein n1 and n2 represent the stoichiometry of said subunits in said complex;

(b) contacting the complex with the sample;

(c) exposing said sample to radiative energy near the excitation wavelength of D and

(d) measuring the fluorescence emitted at the emission wavelength of at least one of D and A.

29. The method of claim 28, wherein the measuring step comprises measuring the fluorescence emitted at the emission wavelengths of both A and D, wherein the extent of energy transfer from D to A is determined by the ratio of the emission amplitude of A to the emission amplitude of D.

30. The method of claim 28, wherein the measuring step comprises measuring the fluorescence emitted at the emission wavelength of D and determining the extent of the energy transfer from D to A by the fluorescence lifetime of D or the rate of photobleaching of D.

31. The method of claim 28, wherein the sample comprises an intact cell and the contacting step comprises incorporating the complex into the cell.

32. The method of claim 31, wherein the contacting step is selected from the group consisting of microinjection, electroporation, lipofection, bead loading and scrape loading.

33. The method of claim 28, wherein D and A are selected from the group consisting of:

fluorescein and tetramethylrhodamine;

a 7-aminocoumarin and dipyrromethene-borate;

an indocarbocyanine and rhodamine X; and

a phycoerythrin and allophycocyanin,

or derivatives thereof,

provided that the selected pair exhibit fluorescence energy transfer.

34. The method of claim 28, wherein the emission wavelength of D and the excitation wavelength of A are about 510 to 550 nm.

35. The method of claim 33 or 34, wherein the fluorochromes are fluorescein and tetramethylrhodamine or derivatives thereof.

36. The method of claim 28, wherein n1 is 2 and n2 is 2.

37. The method of claim 28, wherein S₁ and S₂ are recombinant proteins.

38. The method of claim 28, wherein one protein is a recombinant protein and one protein is derived from mammalian sources.

39. The method of claim 28, wherein S₁ and S₂ are derived from mammalian sources.

40. A method according to claim 28, wherein the measuring step comprises measuring the fluorescence emitted at the emission wavelength of A, wherein the extent of energy transfer from D to A is determined by the amplitude of said emission.

41. A method of preparing a labeled complex comprising (S₁.A) and (S₂.D), wherein S₁ is the regulatory subunit of adenosine 3'"'"', 5'"'"'-cyclic monophosphate dependent protein kinase and S₂ is the catalytic subunit of adenosine 3'"'"', 5'"'"'-cyclic monophosphate dependent protein kinase, and wherein D and A are different fluorochromes the emission wavelength of D overlapping the excitation wavelength of A, and D and A are in sufficiently close proximity to allow radiationless transfer of energy between the fluorochromes, said method comprising:

(a) mixing the labeled subunits S₁ .A and S₂.D under conditions suitable for the formation of a complex comprising {(S₁.A)_n1.(S₂ .D)_n2 }, wherein n1 and n2 represent the stoichiometry of the labeled subunits in said complex; and

wherein said fluorochromes are in sufficiently close proximity to allow radiationless transfer of energy between the fluorochromes; and

(b) recovering the complex.

42. The method of claim 41, wherein the fluorochromes are fluorescein and tetramethylrhodamine, or derivatives thereof.

43. The method of claim 41, wherein S₁ and S₂ are recombinant proteins.

44. The method of claim 41, wherein one protein is a recombinant protein and one protein is derived from mammalian sources.

45. The method of claim 41, wherein S₁ and S₂ are derived from mammalian sources.

46. A method of preparing a labeled complex comprising (S₁.A) and (S₂.D), wherein S₁ is the regulatory subunit of adenosine 3'"'"', 5'"'"'-cyclic monophosphate dependent protein kinase and S₂ is the catalytic subunit of adenosine 3'"'"', 5'"'"'-cyclic monophosphate dependent protein kinase, and wherein D and A are different fluorochromes the emission wavelength of D overlapping the excitation wavelength of A, and D and A in said complex are in sufficiently close proximity to allow radiationless transfer of energy between the fluorochromes, wherein a first complex comprising S₁ and S₂ is attached to fluorochrome A, and a second complex comprising S₁ and S₂ is attached to fluorochrome D;

wherein the subunits of said first and second complexes are separated to obtain labeled subunits S₁.D, S₂.D, S₁.A and S₂.A;

said method comprising mixing said labeled subunits under conditions such that said fluorochromes come in sufficiently close proximity to allow radiationless transfer of energy between the fluorochromes to occur, resulting in the formation of labeled complexes {(S₁.D)_n1.(S₂.A)_n2 } or {(S₁.A)_n1.(S₂.D)_n2 }, wherein n1 and n2 represent the stoichiometry of the labeled subunits.

47. The method of claim 46, wherein the fluorochromes are fluorescein and tetramethylrhodamine, or derivatives thereof.

48. The method of claim 46, wherein S₁ and S₂ are recombinant proteins.

49. The method of claim 46, wherein one protein is a recombinant protein and one protein is derived from mammalian sources.

50. The method of claim 46, wherein S₁ and S₂ are derived from mammalian sources.

51. A method of preparing a labeled complex comprising (S₁.A) and (S₂.D), wherein S₁ is the catalytic subunit of adenosine 3'"'"', 5'"'"'-cyclic monophosphate dependent protein kinase and S₂ is the regulatory subunit of adenosine 3'"'"', 5'"'"'-cyclic monophosphate dependent protein kinase, and wherein D and A are different fluorochromes the emission wavelength of D overlapping the excitation wavelength of A, and D and A in said complex are in sufficiently close proximity to allow radiationless transfer of energy between the fluorochromes, said method comprising:

(a) mixing the labeled subunits S₁.A and S₂.D under conditions suitable for the formation of a complex comprising {(S₁.A)_n1.(S₂.D)_n2 }, wherein n1 and n2 represent the stoichiometry of the labeled subunits in said complex; and

wherein said fluorochromes are in sufficiently close proximity to allow radiationless transfer of energy between the fluorochromes; and

(b) recovering the complex.

52. The method of claim 51, wherein the fluorochromes are fluorescein and tetramethylrhodamine, or derivatives thereof.

53. The method of claim 51, wherein S₁ and S₂ are recombinant proteins.

54. The method of claim 51, wherein one protein is a recombinant protein and one protein is derived from mammalian sources.

55. The method of claim 51, wherein S₁ and S₂ are derived from mammalian sources.

56. A method of preparing a labeled complex comprising (S₁ .A) and (S₂.D), wherein S₁ is the catalytic subunit of adenosine 3'"'"', 5'"'"'-cyclic monophosphate dependent protein kinase and S₂ is the regulatory subunit of adenosine 3'"'"', 5'"'"'-cyclic monophosphate dependent protein kinase, and wherein D and A are different fluorochromes the emission wavelength of D overlaps the excitation wavelength of the other A, and D and A in said complex are in sufficiently close proximity to allow radiationless transfer of energy between the fluorochromes, wherein a first complex comprising S₁ and S₂ is attached to fluorochrome A, and a second complex comprising S₁ and S₂ is attached to fluorochrome D;

wherein the subunits of said first and second complexes are separated to obtain labeled subunits S₁.D, S₂.D, S₁.A and S₂.A;

said method comprising mixing said labeled subunits under conditions such that said fluorochromes come in sufficiently close proximity to allow radiationless transfer of energy between the fluorochromes to occur, resulting in the formation of labeled complexes {(S₁.D)_n1.(S₂.A)_n2 } or {(S₁.A)_n1.(S₂.D)_n2 }, wherein n1 and n2 represent the stoichiometry of the labeled subunits.

57. The method of claim 56, wherein the fluorochromes are fluorescein and tetramethylrhodamine, or derivatives thereof.

58. The method of claim 56, wherein S₁ and S₂ are recombinant proteins.

59. The method of claim 56, wherein one protein is a recombinant protein and one protein is derived from mammalian sources.

60. The method of claim 56, wherein S₁ and S₂ are derived from mammalian sources.